These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7460192)

  • 21. Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
    Honess DJ; Workman P; Morgan JE; Bleehen NM
    Br J Cancer; 1980 Apr; 41(4):529-40. PubMed ID: 7387851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA; Workman P; Brown JM
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract]   [Full Text] [Related]  

  • 26. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
    Tamulevicius P; Bamberg M; Scherer E; Streffer C
    Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
    Strong JM; Schwade JG; Gangji D; Shoemaker DD; Upton DK
    Cancer Clin Trials; 1981; 4(1):41-6. PubMed ID: 7214661
    [No Abstract]   [Full Text] [Related]  

  • 28. Circadian changes in the elimination of misonidazole in mouse.
    Labat C; Malmary MF; Casanovas AM; Patau JP; Oustrin J
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):331-4. PubMed ID: 6658193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
    Jones DH; Bleehen NM; Workman P; Smith NC
    Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
    Workman P; Donaldson J; Smith NC
    Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM; Chapman JD
    Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
    Dische S; Saunders MI; Riley PJ; Hauck J; Bennett MH; Stratford MR; Minchinton AI
    Br J Cancer; 1981 Mar; 43(3):344-9. PubMed ID: 7225285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
    Moore JL; Paterson IC; Newman H; Venables S
    Br J Cancer; 1981 Oct; 44(4):592-6. PubMed ID: 7295516
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
    Shoemaker D; Upton D; Strong J
    Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
    Lee FY; Workman P
    Cancer Chemother Pharmacol; 1986; 17(1):30-7. PubMed ID: 3698174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P; Twentyman PR
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the bioavailability of misonidazole (NSC#261037) in capsule and tablet form and pharmacologic effects of daily dosage.
    VanRaalte G; Phillips TL; Wasserman TH
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):279-82. PubMed ID: 7085383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
    Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
    Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.